This inventor holds 55 USPTO granted patents and 17 published patent applications, plus 5 CIPO patents and 33 EPO patents, primarily in Negative Pressure Therapy. Top assignees: Kci Licensing, Inc., Solventum Intellectual Properties Company, Kci Manufacturing Unlimited Company. Active years: 2008-2026.
Location History:
- San Antonio, TX (US) (2009 - 2023)
- Bulverde, TX (US) (2008 - 2024)
Company Filing History:
34 out of 1,006 
13 out of 303 
3 out of 25 
Years Active: 2008-2026
Areas of Expertise:
Title: Innovations by Shannon C. Ingram: Pioneering Wound Treatment Solutions
Introduction
Shannon C. Ingram, based in Bulverde, TX, is an accomplished inventor with an impressive portfolio of 40 patents. His innovative work primarily focuses on advanced wound treatment technologies, demonstrating his commitment to improving healthcare solutions and patient outcomes.
Latest Patents
Among Shannon's latest contributions are two notable patents that aim to enhance the effectiveness of wound care:
1. **Wound Dressing with Multiple Treatment Zones**: This invention presents a customizable wound treatment system designed for managing various zones of a wound. The system features a dressing composed of a first foam layer for the first zone and a second foam layer for the second zone, along with drape layers that optimize treatment efficacy. It leverages a negative pressure source to create a therapeutic environment for both zones and includes a fluid instillation pump for delivering treatment fluids to the wound.
2. **Short Range Peer-to-Peer Network for Negative Pressure Wound Therapy Devices**: This patent discloses a network system comprised of at least two negative pressure wound therapy (NPWT) devices. The first device includes a wireless radio, user interface, and controller, allowing for real-time communication between devices. This setup enables efficient monitoring and operational adjustments, ensuring effective therapy management.
Career Highlights
Shannon has had a distinguished career, working for reputable companies such as KCI Licensing, Inc. and Allegiance Corporation. His roles in these organizations have centered around the development of innovative solutions, particularly in wound care technology, where his patents have the potential to significantly impact patient treatment protocols.
Collaborations
Ingram has collaborated with notable professionals in the field, including Christopher A. Carroll and Justin R. Rice. These collaborations have enhanced the innovative process, allowing for shared expertise and the development of cutting-edge medical solutions.
Conclusion
Shannon C. Ingram's contributions to the field of wound treatment through his innovative patents are a testament to his dedication and expertise as an inventor. His work not only showcases his technical acumen but also holds the promise of improving patient care in wound management.